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Conclusion: Differentiation of non-ischemic and ischemic LV dysfunction
appears possible with MCE and wall motion analysis. Myocardial stunning
occurred 10% of the time after elective CABG surgery. Intraoperative flow
and chronic function after CABG surgery are strongly linked (96%).
days. Recorded images were analyzed off-line by 3 observers blinded to out-
come. Contrast enhancement of myocardial perfusion at the time of surgery
was also assessed in equally divided LV regions from the short-axis, LV echo
image. Relationships between flow and function were described based on
acute function (AF) (the avg. of scores at 15, 30, and 60 min after CPB).
chronic function (CF) (the avg. of scores at 12 hr., 5 days, and 30 days), and
intraoperative flow score.
Results: There were no significant differences pre- and post-op between
control and contrast groups with respect to CPK enzymes, EKG changes, and
hemodynamics. When coupled to function, flow was measured 60% of the
time (29 of 48) Four relationships of flow and function were defined (function
score of 0-2 = abnormal; 3-4 = normal):
foramen ovale 1, and bicuspid aortic valve 1. Additional surgical procedure
was performed in each of the first 3 patients (4%). Postoperatively, IOTEE de-
tected severe residual mitral regurgitation (MR) with marked systolic anterior
motion (SAM) of the mitral valve in 3, ventricular septal defect in 1 patient, all
of which (5%) were surgically corrected with a second pump run. All 3 cases
of severe residual MR due to inadequate myectomy occurred during early
surgical experience (1988 and 1989). Other 5 (7%) non-surgical postopera-
tive findings included severe MR associated with poor LV function in 1, low
ejection fraction in 2, hypovolemia with hypotension in 1 and regional wall
motion abnormality in 1 patient. The mitral valve was structurally normal in
61 pts (82%1, 3 (4%) had flail PMVL, 4 (5%) had PMVL prolapse, 1 had AMVL
prolapse, 1 had bileaflet prolapse, 1 had valvular calcification and 4 had mitral
annular calcification. SAM was present in 69 (93%) prebypass and was still
present in 45 (61 %) immediate postbypass and was present in 30 (41 %) pre-
discharge. The grade of MR decreased from 2.3 ± 1.0 prebypass to 1.1 ± 0.5
postbypass (p < 0.0001). Absence of post-bypass SAM was associated with
significant postoperative reduction of MR evaluated by IOTEE (p = 0.024).
Conclusion: In patients with HOCM undergoing myectomy, IOTEE is valu-
able in detecting preoperatively unknown cardiac pathologies in 12%, alter-
ing surgical procedure in 4%, and in assessing the result of myectomy, re-
quiring a second pump run in 5%. IOTEE was also valuable in identifying the
etiology of postoperative LV dysfunction in 7% and intrinsic structural abnor-
mality of mitral valve in 19%. Residual SAM detected by IOTEE after septal
myectomy resolves in 33% of Pts by the time of predischarge transthoracic
echo study.
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Dynamic Left Ventricular Outflow Tract Obstruction
Immediately Following Aortic Valve Replacement:
Detection by Intra-operative Trans-esophageal
Echocardiography
Dakshina R. Murthy, Chunguang Chen, Marc A. Paradis, Henry B. Low, Hiro Takata,
Lee H. Ellison, Paul Preissler, Nancy Krupowies, Linda D. Gillam. Hartford Hospital,
University of Connecticut, Hartford, CT
Aortic valve replacement (AVR) produces dramatic acute changes in left ven-
tricular loading conditions that may provide a substrate for dynamic left
ventricular outflow tract (LVOT) obstruction, particularly in the context of in-
otropic stimulation. This and related abnormalities have been described post-
operatively, but their occurrence intra-operatively immediately post AVR has
not been examined. To assess the prevalence and clinical impact of this phe-
nomenon, intra-operative transesophageal echocardiography (TEE) was per-
formed in 72 patients undergoing aortic valve replacement (AVR) for aortic
stenosis (n = 28) aortic regurgitation (n = 15). or mixed aortic valve disease
(n = 29). There were 31 bioprostheses, 23 mechanical valves, and 18 homo-
grafts/autografts.
Results: No pt had dynamic LVOT obstruction on pre-bypass TEE. TEE per-
formed after or during weaning from bypass revealed hemodynamically sig-
nificant dynamic LVOT obstruction characterized by mitral systolic anterior
motion, subvalvular obstruction and variable mitral regurgitation in 5 pts (2
homografts, 2 bioprostheses, 1 mechanical). All these pts had normal left
ventricular function, concentric hypertrophy, and pre-op aortic stenosis ±
aortic insufficiency. Although all 5 pts were hemodynamically unstable (with
difficulty weaning from bypass, variable systemic hypotension, andlor left
atrial hypertension) dynamic LVOT obstruction was not suspected clinically
prior to TEE. All pts improved with cessation of inotropes andlor B-blockade
with coincident improvement, but notelimination of the subvalvulargradient.
Conclusion: Dynamic LVOT obstruction may occur following AVR in the
immediate post-bypass period. This problem is difficult to recognize and may
be inappropriately treated. Intra-operative TEE is essential to diagnose this
problem and monitor therapy.
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Detecting Myocardial Stunning During CABG Surgery
with Myocardial Contrast Echocardiography (MCE)
Solomon Aronson, Anthony Fernandez, Christopher Young, Long Han,
Alicia Toledano, Bryan Lee, Robert Karp, Stephen Feinstein, Robert Savage,
Allan Klein, Bruce Lylel. University of Chicago, Cleveland Clinic, Cleveland, Ohio
During cardiac surgery, differentiating between ischemic and non-ischemic
LV dysfunction is critical for prognosis and therapeutic strategies. We hy-
pothesized that flow determined with myocardial contrast echo and wall
motion analysis would enable identification of stunned myocardium. Twelve
patients who received aortic root injections of AlbunexRcontrast during elec-
tive CABG surgery were compared to 14 matched controls for contrast agent
safety. CPK enzymes, EKG, and hemodynamics were measured (pre- and
post-op) for 72 hr. Baseline wall motion was scored (0-4) in contrast pa-
tients from 4 equally divided LV mid-papillary, short-axis regions and after
CPB at the following intervals: 15,30,60 min.; 12 hr.; 5-8 days; and 30
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inhibition of Neointimal Hyperplasia After Balloon
Injury by Local Delivery of a Cyclic
Arginine-Glycine-Aspartic Acid Peptide Targeting
Vitronectin Receptor
Craig H. Lundgren, Hirofumi Sawa, Satoshi Fujii. Washington University School of
Medicine, St. Louis, MO
We have previously shown that cell-matrix interactions mediated via matrix
protein ligand vitronectin (VN) derived from serum and its cell surface aVfJ3
integrin receptor (VNR) regulate migration of human aortic smooth muscle
cells (SMC) in vitro. Arginine-glycine-aspartic acid (RGD) sequence of VN
(residues 45 to 47) is the critical domain for interactions. In this study we
sought to determine whether interference with VN-VN R interaction in the
arterial wall would alter development of neointimal hyperplasia in a rabbit
model. After balloon-induced injury of the carotid artery (2 fr Fogarty, three
times) serum-derived VN was observed in edematous intima and upper third
of media (immunostaining, n = 3). In 4 rabbits the VNR antagonist cyclic
RGD peptide (1 mM) was locally applied to the injured artery by use of F-127
gel (800 iLII. RAD peptide (1 mM) served as an inactive control (n = 4). At
28 days rabbits were killed and carotid arteries were fixed and mean intima
and media area was determined by computer-assisted planimetry. The mean
intimalmedia ratio in control balloon-injured arteries was 0.47 ± 0.04 (SD). In
injured, cyclic RGD peptide-treated arteries the intimalmedia ratio was 0.11
± 0.02 (p < 0.01). There was no significant difference in media area in the
two groups (1.84 ± 0.22 vS 1.67 ± 0.14 mm2). These results suggest that 1)
VN-VNR interaction mediates SMC migration in vivo, and 2) localized applica-
tion of a VNR antagonist to the arterial wall after balloon injury modifies this
process and results in a significant reduction in the development of neoin-
timal hyperplasia. VN-VNR interaction may be an additional attractive target
for pharmacologic manipulations aimed at limiting restenosis after vascular
Injury.
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1713-21 All Trans-retinoic Acid and Its Derivatives inhibit
Serotonin-induced Vascular Smooth Muscle Cell
Proliferation
RaJbabu Pakala, Peter J.A. Davies, Rosh Chandraratna, Claude R. Benedict.
University of Texas Medical School, Houston, 7)(. Aliergan Inc., Irvine, CA
Background: Serotonin (5HTl. released from aggregating platelets at sites of
vascular injury following coronary angioplasty, is a known mitogen for vascu-
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lar smooth muscle cells (SMC). Retinoids have been shown to inhibit cellu-
lar proliferation possibly due to effects on cytokines, cytokine receptors and
proto-oncogene expression.
Objective: In this study we examined whether all trans retinoic acid (RA) or
its derivatives 13-Cis RA and 9-Cis RA would prevent the 5HT induced SMC
proliferation as determined by 3[H)-thymidine incorporation into DNA.
Methods: Canine aortic primary SMC (in 2nd or 3rd passage) were in-
cubated with different concentration of RA 13-Cis RA or 9-Cis RA and
200}LM of serotonin for 20 hours in serum free medium. Then 3[H)-thymidine
(1 }LCi/plate) was added and 3[H]-thymidine incorporation into SMC was mea-
sured 4 hours later.
Results: The 200}LM of serotonin induced approximatel~ a 3-4 fold in-
crease in 3[H)-thymidine incorporation (5570 ± 242 cpm/l 0 cells to 18202
± 881 cpm/l06 cells) in SMC (n = 5). All three retinoids inhibited serotonin
induced SMC proliferation. The dose of retinoids that produced a 50% re-
duction in DNA (p < 0.00011 synthesis in SMC were 47nM for RA 410nM
for 9-Cis RA and 5}LM for 13-Cis RA. There was no evidence of cytotoxicity
with any of the retinoids to SMC up to a concentration of 1-5 mM.
Conclusion: Retinoids prevent 5HT induced SMC proliferation at low con-
centrations. Since 5HT released from platelets at sites of vascular injury may
playa role in the development of neointimal proliferation following coronary
angioplasty, retinoids may potentially be useful for prevention of restenosis
following angioplasty.
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1713-31 P-Blocker Agents Prevent Oxygen Radical-induced
Human Apolipoprotein-B lOO Oxidation
Claudio Napor" Giuseppe Ambrosio, Giuseppe Palumbo 1, Claudia Miele 1 ,
Paola Chiariello, Annalisa Scognamiglio, Mario Condorelli, Massimo Chiariello. Di~
of Cardiology; Dept. ofMedicine, "Federico II" University ofNaples, It.aly: 1 Dept.. of
Molecular Pat.hology; "Federico II" University ofNaples, It.aly
Oxygen radicals may induce both peroxidation of polyunsaturated lipids and
protein alterations in low density lipoprotein (lDl). Oxidized lDl taken up by
macrophages via the "scavenger" receptor may contribute to formation of
foam cells. Previous studies have shown that p-blocker agents reduce exper-
imental atherosclerosis in primates. In addition, we have previously shown
that p-blocker agents inhibit oxygen radical-induced lipid peroxidation. Thus,
in this study we have investigated whether p-blockers may prevent oxidative
modifications induced by oxygen radicals on apolipoprotein-B lOO (apo-B lOO )
of lDL. Purified human lDl was exposed to oxygen radicals generated by
CuS04 (15 }LM for 20 hs at 37' C) under control conditions, or after a 30 min
pre-incubation with propranolol (P: 1-10 mM). The index of peroxidation mal-
onildihaldehyde, by thiobarbiturate method, was 2.1 ± 0.5* nmoles/mg of
protein in native lDl, 34.5 ± 4.1 in control lDL and decreased to 6.5 ± 1.8*
in lDl incubated with P (*p < 0.01 vs controls I. When oxidized lDl was run
on SDS-polyacrylamide electrophoresis (SDS-PAGE: 5 to 10% gradient) ex-
tensive apo-B lOO fragmentation was observed. Addition of P prevented the
apo-BlOO fragmentation (mean reduction from 12 to 3 bands of low molecu-
lar weight). Moreover, oxidized lDl had increased mobility on 0.8% agarose
gel electrophoresis (2.8 ± 0.4 time than controls). Similarly, incubation with
P reduced lDl mobility to 0.8 ± 0.2 fold in respect to controls (p < 0.05).
These data demostrate protection by propranonol on apo-B lOO oxidation
in vitro, at clinically relevant concentrations. Although p-blockers are known
to adversely affect lipid metabolism, inhibition of both lDl peroxidation and
apo-BlOo fragmentation may reduce uptake of oxidized lDl by macrophages
and hence foam cell formation.
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Inhibition of Vascular Superoxide Production in
Hypercholesterolemic Rabbit Aorta by L-Arginine
Contributes to Restored Endothelium-dependent
Relaxation
Rainer H. B6ger, Stefanie M. Bode-Boger, Andreas MOgge 1, Sven Kienke,
Alex Dwenger 2, Jor~en C Fr6lich. Dpt. of Clinical Pharmacology, Medical School,
Hannover, Germany; Dpt. of Cardiology, Medical School, Hannover, Germany; 2 Dpt.
of Clinical Biochemistry, Medical School, Hannover. Germany
Chronic oral administration of L-arginine (l-ARG) has been shown to enhance
endothelial function in cholesterol (CHOl)-fed rabbits and to reduce athero-
genesis. We investigated whether modulation of endogenous NO produc-
tion (as assessed by urinary NO::; excretion) by l-ARG and the inhibitor of
NO synthesis, l-NAME, affects vascular superoxide (°2: 1production in hy-
percholesterolemic rabbits. Phorbol-myristate-acetate (PMA)-stimulated 02:
production from isolated aortic rings was increased in rabbits given CHOl
(+ 159 ± 28%) or CHOl + l-NAME (+ 149 ± 37%) as compared to con-
trols (-22 ± 7%), and endothelium-dependent relaxations by acetylcholine
were diminished in both groups. In aortic rings from rabbits given CHOl +
l-ARG, PMA-induced 02: production was restored to control levels (+ 14 ±
17%; p < 0.05), and endothelium-dependent cholinergic relaxations were
also partly restored. Urinary NO; excretion decreased in all animals fed a
CHOl-enriched diet (p < 0.01). As NO inactivated by 02: is also oxidized to
NO::;, this indicates a decreased endothelial production of NO. NO::; excretion
was further decreased by l-NAME (p < 0.05 vs. CHOl), and partly restored
by l-ARG (p < 0.05). We conclude that both a decreased production of NO
and an enhanced breakdown of NO by 02: contribute to the diminished bi-
ological activity of endothelial NO in hypercholesterolemia. l-ARG restores
endothelial function by enhancing NO formation and by protecting NO from
early breakdown by 02:.
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1713-51 N"'-nitro-L-arginine Methyl Ester Increases Mural
Platelet Deposition and Neutrophil-endothelial
Interactions Under Low and High Shear Conditions
Patrick Provost, Jules Y.T. Lam. Montreal Heart Inst.it.ute, Montreal, Quebec, Canada
Whether infusion of a nitric oxide (NO) synthesis inhibitor, Nw-nitro-l-arginine
methyl ester (l-NAME), can modulate mural platelet deposition and neu-
trophil interaction with the endothelium underflow conditions was examined
in ex vivo bioassay experiments. Porcine aortic media, simulating deep arte-
rial wall injury, or porcine aortic endothelium was exposed to flowing arterial
blood from l-NAME-treated pigs for 5 min at 37'C under low (424 sec')
and high (3397 secl ) shear conditions in superfusion flow chambers. In-
travenous administration of l-NAME (3 mg/kg bolus + 3 mg/kg/h perfusion)
increased systolic (from 82.2 ± 2.7 to 108.5 ± 3.8 mmHg; p < 0.001). di-
astolic (from 47.4 ± 2.1 to 76.6 ± 3.6 mmHg; p < 0.001) and mean (from
59.0 ± 2.2 to 87.2 ± 3.6 mmHg; p < 0.001) arterial blood pressures with a
slight reduction in heart rate (from 155 ± 8 to 139 ± 7 beats/min: p < 0.01).
51 Cr platelet deposition on aortic media exposed to low and high shear rates
was increased, respectively, from 15.9 ± 2.9 to 20.4 ± 2.8 x 106/cm2 (p <
0.05) and from 71.4 ± 11.9 to 95.8 ± 12.5 x 106/cm2 (p < 0.02) following l-
NAME treatment. 11 'In neutrophil adhesion to intact endothelium was also
enhanced by l-NAME from 9.8 ± 2.4 to 18.3 ± 5.2 x 103/cm2 (p < 0.03)
and from 12.5 ± 4.1 to 29.1 ± 8.8 x 103/cm2 (p < 0.02) under respectively
low and high shear rates. However, platelet interaction with the endothelium
remained low and the endothelium maintained its thromboresistance.
Conclusion: Administration of the specific inhibitor of NO synthesis l-
NAME increased arterial blood pressure and enhanced platelet interaction
with the injured vessel wall and neutrophil adhesion to thromboresistant en-
dothelium under low and high shear conditions.
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1713-61 Functional and Metabolic Protection of the Ischemic
Rabbit Heart by NO Synthase Inhibitor
Christophe Depre, Jean L. Vanoverschelde, Louis Hue. Uni~ ofLouvain Med.
School, Brussels, Belgium
To assess the role of the NO pathway in ischemic injury, the NO synthase
inhibitor l-N-Monomethylarginine (l-NMMA) was tested on isolated rab-
bit hearts retrogradely perfused with Krebs-Henseleit buffer containing 5.5
mM glucose and submitted to 30 min equilibration at 5 ml/min per g, fol-
lowed by a 60 min low-flow ischemia (10% baseline) and 30 min reperfu-
sion. Metabolic and physiological parameters of hearts treated with 1 }LM l-
NMMA added 15 min before ischemia (n = 10) were compared with similar
parameters in controls (ctrl, n = 15) without the inhibitor. Before ischemia,
l-NMMA did not influence left ventricular developed pressure or coronary
perfusion pressure but lowered cyclic GMP by 25% (P = 0.01). During is-
chemia, l-NMMA decreased the severity of ischemic contracture (25 ± 3 vs
54 ± 4 mmHg in ctrl, P < 0.001) Perfusion with D-NMMA did not protect the
heart against ischemic contracture. The effect of l-NMMA was suppressed
by 1 mM L-arginine or 10 }LM sodium nitroprussiate but not by 10 }LM 8-
Br-cyclic GMP. a cyclic GMP analogue. At the end of ischemia, exogenous
glucose uptake was 0.90 ± 0.08 and 4.0 ± 0.2 }Lmol/min per g DW (P <
0.0ll. lactate production was 4.0 ± 0.7 and 8.0 ± 0.7 }Lmollmin per g DW
(P < 0.01), glycogen was 15 ± 2 and 29 ± 5 }Lmol glucose eqJg DW (P <
0.01) and ATP was 2.5 ± 0.4 and 4.6 ± 0.3 }Lmollg DW (p < 0.01) in ctrl and
treated hearts, respectively. With reperfusion, the developed pressure was
doubled (65 ± 5 vs 32 ± 3 mmHg, P < 0.001) and the CPK release reduced
by 50% (P < 0.01) in hearts treated with l-NMMA vs ctrl. A dose-response
curve of protection against ischemic damage by l-NMMA showed that the
NO synthase inhibitor decreased ischemic contracture and enhanced glu-
cose uptake between 1 nM and 1 /LM, i.e. below concentrations inducing
vasoconstriction. It is concluded that l-NMMA protects the ischemic rab-
bit heart against cellular damage by stimulating exogenous glucose uptake,
thereby preserving endogenous energetic resources as glycogen. This pro-
tection during ischemia leads to an improvement of post-ischemic functional
recovery. This effect during ischemia seems cGMP-independent.
